Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities

Paloma Caballero1, Rodrigo Alonso, Paloma Rosado

  • 1Department of Radiology, Hospital de la Princesa, Madrid, Spain.

Atherosclerosis
|March 31, 2012
PubMed

Insights

Asymptomatic familial hypercholesterolemia (FH) patients show increased atherosclerosis burden compared to controls. Advanced imaging like MRI detected lipid-rich plaques, linked to early heart disease history.

Area of Science:

  • Cardiovascular Imaging
  • Atherosclerosis Research
  • Genetic Lipid Disorders

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high LDL cholesterol and premature cardiovascular disease.
  • Subclinical atherosclerosis assessment in asymptomatic FH patients is crucial for risk stratification.
  • Non-invasive imaging techniques offer valuable insights into early atherosclerotic changes.

Purpose of the Study:

  • To quantify subclinical atherosclerosis in asymptomatic familial hypercholesterolemia (FH) patients.
  • To compare atherosclerotic burden between FH patients and healthy controls using imaging.
  • To explore the correlation between different imaging markers and family history.

Main Methods:

  • Magnetic Resonance Imaging (MRI) of the descending thoracic aorta to measure aortic wall volume and characterize plaques.
  • B-mode carotid ultrasound to assess carotid intima-media thickness (cIMT) and detect carotid plaques.
  • Comparison of imaging findings between 36 FH patients and 19 controls.

Main Results:

  • FH patients exhibited significantly higher aortic wall volume, cIMT, and aortic plaques compared to controls (P<0.001).
  • A significant positive correlation was found between aortic wall volume and cIMT (P<0.01).
  • MRI detected plaques in 94% of FH cases; lipid-rich plaques were identified in 33% and associated with a family history of premature coronary artery disease (P<0.05).

Conclusions:

  • Asymptomatic FH patients have a substantially elevated atherosclerotic burden.
  • cIMT correlates with aortic wall volume, suggesting widespread atherosclerosis.
  • MRI is effective in detecting lipid-rich plaques in FH patients, indicating increased cardiovascular risk.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...